CA3196153A1 - Pyrido[4,3-b]indole derivatives and their use as pharmaceuticals - Google Patents
Pyrido[4,3-b]indole derivatives and their use as pharmaceuticalsInfo
- Publication number
- CA3196153A1 CA3196153A1 CA3196153A CA3196153A CA3196153A1 CA 3196153 A1 CA3196153 A1 CA 3196153A1 CA 3196153 A CA3196153 A CA 3196153A CA 3196153 A CA3196153 A CA 3196153A CA 3196153 A1 CA3196153 A1 CA 3196153A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- substituted
- unsubstituted
- disease
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063082695P | 2020-09-24 | 2020-09-24 | |
| US63/082,695 | 2020-09-24 | ||
| PCT/US2021/051670 WO2022066851A1 (en) | 2020-09-24 | 2021-09-23 | PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3196153A1 true CA3196153A1 (en) | 2022-03-31 |
Family
ID=80846865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3196153A Pending CA3196153A1 (en) | 2020-09-24 | 2021-09-23 | Pyrido[4,3-b]indole derivatives and their use as pharmaceuticals |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240018138A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4216940A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023543254A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116209442A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021349249A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196153A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022066851A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230124665A (ko) | 2020-12-22 | 2023-08-25 | 노파르티스 아게 | Cgas 관련 병태의 치료에 유용한 인돌 유도체 |
| WO2023183275A1 (en) * | 2022-03-22 | 2023-09-28 | Ventus Therapeutics U.S., Inc. | Hexahydropyrido[4,3-b]indolyl ketone derivatives useful as cgas modulators |
| CN121248633A (zh) * | 2022-11-09 | 2026-01-02 | 勃林格殷格翰国际有限公司 | 作为cGAS抑制剂的环状苯并咪唑衍生物 |
| CN120769854A (zh) * | 2022-12-21 | 2025-10-10 | 伊莱利利公司 | 氮杂䓬并[4,5-B]吲哚酮cGAS抑制剂 |
| AR133584A1 (es) | 2023-08-18 | 2025-10-15 | Univ Leuven Kath | Nuevos compuestos |
| CN119490508A (zh) * | 2023-08-21 | 2025-02-21 | 上海交通大学 | 一类螺环四氢-γ-咔啉衍生物的制备方法以及应用 |
| WO2025218659A1 (en) * | 2024-04-16 | 2025-10-23 | Insilico Medicine Ip Limited | Novel compounds as cyclic gmp-amp synthase inhibitor and uses thereof |
| WO2026026969A1 (zh) * | 2024-08-01 | 2026-02-05 | 杭州英创医药科技有限公司 | 作为cGAS抑制剂的化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011019417A1 (en) * | 2009-04-29 | 2011-02-17 | Medivation Technologies, Inc. | Pyrido [4, 3-b] indoles and methods of use |
| CN109311876B (zh) * | 2016-06-16 | 2022-05-03 | 豪夫迈·罗氏有限公司 | 杂芳基雌激素受体调节剂及其用途 |
| JP2021506862A (ja) * | 2017-12-19 | 2021-02-22 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Tlr7/8アンタゴニストおよびそれらの使用 |
| MX2020008237A (es) * | 2018-02-05 | 2020-09-25 | Univ Rockefeller | Inhibidores de 2,3,4,5-tetrahidro-1h-pirido[4,3-b]indol de cgas para tratar enfermedades autoinflamatorias. |
| WO2020142729A1 (en) * | 2019-01-04 | 2020-07-09 | BellBrook Labs | Inhibitors of cgas activity as therapeutic agents |
| WO2020186027A1 (en) * | 2019-03-13 | 2020-09-17 | Daisuke Tomita | Inhibitors of cgas for treating autoinflammatory diseases and cancer metastasis |
-
2021
- 2021-09-23 EP EP21873398.8A patent/EP4216940A4/en active Pending
- 2021-09-23 US US18/027,602 patent/US20240018138A1/en not_active Abandoned
- 2021-09-23 JP JP2023519165A patent/JP2023543254A/ja active Pending
- 2021-09-23 CA CA3196153A patent/CA3196153A1/en active Pending
- 2021-09-23 WO PCT/US2021/051670 patent/WO2022066851A1/en not_active Ceased
- 2021-09-23 CN CN202180065543.XA patent/CN116209442A/zh active Pending
- 2021-09-23 AU AU2021349249A patent/AU2021349249A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023543254A (ja) | 2023-10-13 |
| US20240018138A1 (en) | 2024-01-18 |
| WO2022066851A1 (en) | 2022-03-31 |
| AU2021349249A1 (en) | 2023-04-13 |
| EP4216940A1 (en) | 2023-08-02 |
| EP4216940A4 (en) | 2025-01-01 |
| CN116209442A (zh) | 2023-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113286794B (zh) | Kras突变蛋白抑制剂 | |
| WO2022066851A1 (en) | PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | |
| CN112638380B (zh) | 小脑蛋白(crbn)配体 | |
| CN116390923B (zh) | 杂环类衍生物及其制备方法和用途 | |
| JP7711073B2 (ja) | 免疫抑制剤として有用な大環状pad4阻害剤 | |
| JP2021535909A (ja) | 高活性stingタンパク質アゴニスト化合物 | |
| EP3917926B1 (en) | Imidazoquinoline amine derivatives, pharmaceutical composition, use thereof | |
| KR101272263B1 (ko) | 감염 방지제로서 사용되는8-메톡시-9h-이소티아졸로[5,4-b]퀴놀린-3,4-디온 및관련 화합물 | |
| AU2012293618B2 (en) | Antibacterial homopiperidinyl substituted 3,4 dihydro 1H (1,8)naphthyridinones | |
| CN114641472A (zh) | 用于治疗疾病的双亮氨酸拉链(dlk)激酶的双环[1.1.1]戊烷抑制剂 | |
| US11858938B2 (en) | Imidazo-fused heterocycles and uses thereof | |
| CN119173505A (zh) | 抗病毒杂环化合物 | |
| AU2023254925A1 (en) | Imidazo[1,5-a]pyrazine derivatives as PI3Kdelta inhibitors | |
| WO2023143249A1 (zh) | 靶向malt1的蛋白降解化合物 | |
| JP2018531993A (ja) | Alkおよびsrpk阻害剤ならびに使用方法 | |
| KR20240121746A (ko) | 테트라하이드로피리다진, 이를 포함하는 조성물, 및 이의 용도 | |
| RS55201B1 (sr) | Antimalarijski agensi | |
| CA3087926A1 (en) | Cycloalkyl substituted pyrazolopyrimidines having activity against rsv | |
| WO2021233394A1 (en) | Receptor-interacting protein 1 inhibitors including piperazine heterocyclic amide ureas | |
| WO2016196910A1 (en) | Compounds for the modulation of myc activity | |
| US20240132464A1 (en) | Heterocyclic compounds as e3 ligase inhibitors | |
| HK40093069A (en) | Pyrido[4,3-b]indole derivatives and their use as pharmaceuticals | |
| KR20260025059A (ko) | 신규한 치환된 피리딘 유도체 화합물, 이의 제조방법, 및 이를 유효성분으로 포함하는 호흡기 질환의 예방 또는 치료용 약학적 조성물 | |
| US20210221820A1 (en) | Compounds for the modulation of myc activity | |
| WO2024207131A1 (en) | Ferroptosis inhibitors–phenoxazine acetamides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240826 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240826 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240826 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251106 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260310 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20260323 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-6-6-B10-B12-B301 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO A REQUEST FOR EXAMINATION NOTICE Effective date: 20260511 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260709 |